You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 2 Monotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Refractory Ewing Sarcoma
  • +2 more
  • (no location specified)
Feb 15, 2023

HER-2 Positive Advanced Solid Tumors Trial (D3L-001)

Not yet recruiting
  • HER-2 Positive Advanced Solid Tumors
  • D3L-001
  • (no location specified)
Jul 20, 2023

Tumors, Rectal Trial (Dostarlimab)

Not yet recruiting
  • Neoplasms, Rectal
  • Dostarlimab
  • (no location specified)
Feb 2, 2023

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in

Not yet recruiting
  • Ovarian Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
  • (no location specified)
Jan 31, 2023

Diabetes Trial (DA-2811, Forxiga)

Not yet recruiting
  • Diabetes Mellitus
  • (no location specified)
Feb 15, 2023

Advanced Solid Tumors With MAPK Pathway Mutations Trial in Nedlands (D3S-002)

Not yet recruiting
  • Advanced Solid Tumors With MAPK Pathway Mutations
  • Nedlands, Western Australia, Australia
    D3 Bio Investigative Site
May 24, 2023

Hepatocellular Carcinoma Trial (Pembrolizumab)

Active, not recruiting
Has Results
  • Hepatocellular Carcinoma
  • Pembrolizumab
  • (no location specified)
Dec 15, 2022

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Advanced Solid Tumor Trial in Shanghai (DB-1202)

Not yet recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 29, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 31, 2023

Breast Cancer, Advanced Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University
Nov 9, 2022

Advanced Solid Tumors Trial in Huntersville, Cleveland (2X-121 and dovitinib)

Recruiting
  • Advanced Solid Tumors
  • 2X-121 and dovitinib
  • Huntersville, North Carolina
  • +1 more
Feb 1, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Atopic Dermatitis Trial in Newark (BSI-045B, Dupilumab)

Not yet recruiting
  • Atopic Dermatitis
  • Newark, Delaware
    Biosion USA, Inc.
Jul 7, 2023

Depression, Depressive Disorder, Depressive Symptoms Trial (TNX-601 ER, Placebo)

Not yet recruiting
  • Depression
  • +5 more
  • TNX-601 ER
  • Placebo
  • (no location specified)
Jan 6, 2023

Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer Trial (HST-1011, Cemiplimab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
Dec 14, 2022

Solid Tumor, Peritoneal Metastases, Peritoneal Cancer Trial in Haifa, Jerusalem, Ramat Gan (Allocetra-OTS, nivolumab)

Recruiting
  • Solid Tumor
  • +2 more
  • Haifa, Israel
  • +2 more
Oct 12, 2022

Solid Tumor, Adult Trial in Shanghai (3D011-08)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Floor 2, Building 2, 270 Dong 'an Road, Xuhui District, China
    Fudan University Shanghai Cancer Center
Jan 2, 2023

Selected Subjects With Advanced Solid Tumors Trial in Guangzhou (SKB264)

Not yet recruiting
  • Selected Subjects With Advanced Solid Tumors
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 18, 2022

Non Small Cell Lung Cancer Trial (Tislelizumab, Ociperlimab, LBL-007)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Jan 30, 2023

Advanced or Metastatic Solid Tumors Trial in Toronto, Genève, Bellinzona (MK-6598, Pembrolizumab)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Toronto, Ontario, Canada
  • +2 more
Jan 19, 2023

Relapsing Forms of Multiple Sclerosis Trial (BIIB091, DRF, Placebo)

Not yet recruiting
  • Relapsing Forms of Multiple Sclerosis
  • (no location specified)
Mar 23, 2023